![](https://img.einpresswire.com/small/588848/reglagene-logo.png)
Reglagene Expands to Houston and Joins TMC's Accelerator for Cancer Therapeutics
Will speed development of RGN6024 therapy into the clinic TUCSON, AZ, USA, March 4, 2024 /EINPresswire.com/ -- Reglagene, Inc. announces its expansion to Houston, coinciding with being added to Texas Medical Center’s (TMC) Accelerator for Cancer …